DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Piramal Pharma Limited — Press Release

NSE 1 hr ago·27 Oct 2026, 3:34 pm

Piramal Pharma

Piramal Pharma Limited has announced its financial results for the second quarter and the first half of fiscal year 2026. The company has filed a press release with the stock exchange to disclose these performance metrics, which cover the period ending September 30, 2025. This update provides investors with a formal record of the company's operational and financial standing during this specific timeframe.

This announcement is significant for shareholders as it offers a clear view of the company's current trajectory. By reviewing the reported figures, investors can assess the company's progress against its targets and evaluate its performance relative to market expectations. This data is crucial for making informed decisions regarding the stock's future potential.

Investors should closely monitor the detailed financial statements accompanying the release. Key areas of focus will include the company's revenue growth, profit margins, and any commentary provided by management regarding future outlooks. Tracking these factors will help in understanding the company's competitive position and strategic direction.